STOCK TITAN

Schrodinger's Robert Lorne Abel sells 23,605 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Schrodinger, Inc. EVP, Chief Scientific Officer, Platform Robert Lorne Abel exercised options to acquire 21,927 shares at $17 per share on November 11, 2026, then sold 23,605 shares at $34 per share. The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted November 25, 2025.

After the exercise, 72,829 options remained reported. The exercised option was fully vested and expires February 5, 2030.

Insider Abel Robert Lorne
Role See Remarks
Sold 23,605 shs ($803K)
Approx. gross sale proceeds $803K
Approx. exercise cost $373K
Type Security Shares Price Value
Exercise Stock Option (right to buy) F1, F3 21,927 $0.00 $0.00
Exercise Common Stock F1 21,927 $17.00 $373K
Sale Common Stock F1 21,927 $34.00 $746K
Sale Common Stock F1, F2 1,678 $34.00 $57K
Holdings After Transaction: Stock Option (right to buy) — 72,829 options (Direct); Common Stock — 54,219 shares (Direct)
Footnotes (3)
  1. F1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2025.
  2. F2. Includes 49,824 unvested RSUs.
  3. F3. This option was granted on February 5, 2020 and is fully vested.
Shares acquired through option exercise 21,927 shares November 11, 2026
Option exercise price $17 per share Exercise on November 11, 2026
Shares sold 23,605 shares Two sales on November 11, 2026
Sale price $34 per share Sales on November 11, 2026
Options following exercise 72,829 options Reported following the November 11, 2026 exercise
Additional shares sold 1,678 shares Sale on November 11, 2026
Rule 10b5-1 trading plan regulatory
"effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
unvested RSUs financial
"Includes 49,824 unvested RSUs."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SDGR shares did Robert Lorne Abel sell on November 11, 2026?

Robert Lorne Abel sold 23,605 Schrodinger, Inc. common shares at $34 per share on November 11, 2026. The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted November 25, 2025.

How many SDGR options did Robert Lorne Abel exercise, and at what price?

Robert Lorne Abel exercised options to acquire 21,927 shares at $17 per share on November 11, 2026. The reported remaining option position was 72,829 options; the exercised option was granted February 5, 2020, was fully vested, and expires February 5, 2030.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Abel Robert Lorne

(Last)(First)(Middle)
C/O SCHRODINGER, INC.,
1540 BROADWAY, 24TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Schrodinger, Inc. [ SDGR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/11/2026M(1)21,927A$1777,824D
Common Stock11/11/2026S(1)21,927D$3455,897D
Common Stock11/11/2026S(1)1,678D$3454,219D(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$1711/11/2026M(1)21,927 (3)02/05/2030Common Stock21,927$072,829D
Explanation of Responses:
1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2025.
2. Includes 49,824 unvested RSUs.
3. This option was granted on February 5, 2020 and is fully vested.
Remarks:
EVP, Chief Scientific Officer, Platform
/s/ Donald Shum, as attorney-in-fact for Robert Lorne Abel11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading